Navigation Links
CVS Caremark Named One of America's Most Reputable Companies by Reputation Institute
Date:4/5/2011

WOONSOCKET, R.I., April 5, 2011 /PRNewswire/ -- CVS Caremark has been named as one of the most reputable companies in the United States, according to the 2011 Most Reputable Companies list published today by Forbes magazine in partnership with the Reputation Institute.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Of the 150 companies included in the survey, CVS Caremark ranked 30th. Survey respondents rated companies on financial performance, products and services, innovation, workplace, governance, citizenship and leadership.

"This recognition is a testament to the hard work that CVS Caremark colleagues do every day on behalf of our clients, customers and plan members in providing them with innovative solutions in pharmacy and health care," said CVS Caremark President and CEO Larry J. Merlo. "We are committed to building on the work we have done to date to do even more to support the goals of our patients, our clients and the communities we serve."

Reputation Institute's Global RepTrak™ Pulse is the largest study of corporate reputations in the world, identifying what drives reputation and covering more than 2,500 companies from 41 countries annually. Reputation Institute provides specific reputation insight from more than 15 different stakeholder groups and 24 industries.  

About CVS Caremark

CVS Caremark (NYSE: CVS) is the largest pharmacy care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,100 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's Web site at http://info.cvscaremark.com/.

Media Contact:
Carolyn Castel
CVS Caremark
(401)770 5717
ccastel@cvs.com


'/>"/>
SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs
2. CVS Caremark Charitable Trust Makes Initial Donation of $100,000 to Relief Effort in Japan
3. CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support
4. CVS Caremark and Universal American Announce Termination of Hart-Scott-Rodino Waiting Period
5. CVS Caremark Awarded Pharmacy Benefit Management Institute Rx Benefit Innovation Award for Pharmacy Advisor Program
6. CVS Caremark Corporation to Hold Fourth Quarter 2010 Conference Call
7. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
8. CVS Caremark Announces Interim Leadership for Retail Business
9. CVS Caremark Study Finds Patients with Complex Therapies Struggle to Stay Adherent to their Medications
10. CVS Caremark Study Finds Medication Adherence Leads to Lower Health Care Costs, Even After Accounting for Increased Prescription Drug Spending
11. CVS CAREMARK to Purchase Universal Americans Medicare Part D Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
Breaking Medicine News(10 mins):